Earum Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 30/01/2024 to consider and approve Proposal of raising of funds by way of issue of Warrants (hereinafter referred to as 'Convertible Warrants'), subject to the receipt of necessary approvals.
The above information is a part of company’s filings submitted to BSE.